12 results
10-K
2021 FY
EX-10.13
CADL
Candel Therapeutics Inc
29 Mar 22
Annual report
8:46am
an original, but all of which together shall constitute one and the same instrument.
(l) As used in this Agreement, the masculine, feminine or neuter gender
S-1/A
EX-10.5.6
CADL
Candel Therapeutics Inc
16 Jul 21
IPO registration (amended)
6:07am
and the same instrument.
(l) As used in this Agreement, the masculine, feminine or neuter gender, and the singular or plural, shall be deemed to include
DEF 14A
CADL
Candel Therapeutics Inc
2 Sep 22
Definitive proxy
8:30am
, including diversity of expertise, experience, demographic background and gender, and are committed to identifying, recruiting and advancing candidates … Not
Disclose
Gender
Part I: Gender Identity
Directors
Part II: Demographic Background
African American or Black
Alaskan Native or Native American
Asian
S-1/A
EX-10.1
dug pz2tsgc4hkl324
16 Jul 21
IPO registration (amended)
6:07am
S-1
prel07qz
25 Jun 21
IPO registration
5:28pm
DRS/A
ud6gfaryi4zmuuwi
31 Mar 21
Draft registration statement (amended)
12:00am
S-1/A
uojajrzh3omvdaztihx
16 Jul 21
IPO registration (amended)
6:07am
424B4
fa4m0itcg8u4c5p 1u
28 Jul 21
Prospectus supplement with pricing info
4:02pm
- Prev
- 1
- Next